Abstract:Objective To construct the replication-deficient recombinant adenovirus carrying vasostatin gene and study its inhibitory effect on pancreatic cancer. Methods A cDNA clone encoding vasostatin was isolated from human skeletal muscle cDNA library by polymerase chain reaction. The shuttle plasmid, pshuttle-CMV-vasostatin, in which the amplified fragment was inserted into the downstream of the cytomegalovirus promoter, was established by ligation. After identification by digestion and sequencing, linearize the shuttle plasmid with Pme I, and then transform the linearized shuttle plasmid into E.coli BJ5183-AdEasy-1 by electroporation. The plasmid was named as pAd-CMV-vasostatin after homologous recombination and identification by kanamycin-selection and restriction digestion. The recombinant plasmid was transfected into cell 293. The recombinant adenovirus was detected by examining the presence of cytopathic effect and identified by polymerase chain reaction. Both RT-PCR and western blotting were used to identify the expression of vasostatin. The xenografted nude mice with pancreatic cancer were established to observe the inhibitory effect of vasostatin on tumor growth. The volume of xenografts was measured every three days during the 3-week treatment. The weight of xenografts was measured at the end of the 21st day. Results The PCR product was about 560 bp confirmed by agarose gel electrophoresis. The successful cloning of vasostatin into pshuttle-CMV was confirmed by restriction endonuclease analysis, and the gene of interest was identified as vasostatin by nucleotides sequencing technique. The recombinants were selected for kanamycin resistance and the recombination was confirmed by the presence of 4.5kb fragment in the restriction endonuclease analysis. The cytopathic effect present after 7 days in cell 293 transfected with linearized pAd-CMV-vasostatin. Both the cytopathic effect of cell 293 and the 560 bp PCR producet indicated the presence of the recombinant adenovirus containing vasostatin gene. The expression of vasostatin was identified by RT-PCR and western blotting. The volume and weight of xenografts in pAd-CMV-vasostatin group were significantly smaller than those in pAd-CMV-LacZ group and PBS group. Conclusion The recombinant adenovirus containing vasostatin gene was constructed successfully, and could significantly inhibit the growth of xenografted pancreatic cancer in nude mice.

Inhibitory effect of vasostatin on vascular endothelial cells.

Inhibitory Effect of Vasostatin on Migration of Pancreatic Cancer Endothelial Cells.

Effect of Vasostatin Gene Mediated by Adenovirus on the Proliferation and Apoptosis of Vascular Endothelial Cells

Treatment of Pancreatic Carcinoma by Adenoviral Mediated Gene Transfer of Vasostatin in Mice

Construction of Replication-Deficient Recombinant Adenovirus Carrying Vasostatin Gene and Its Inhibitory Effect on Pancreatic Cancer

Research Progress of Human Angiogenesis Inhibitor Vasostatin

Inhibitory Effects of Endostatin-Vascular Endothelial Growth Inhibitor Recombinant Adenoviruses on Neovascularization

Effect of Antisense Oligodeoxynucleotide of Vascular Endothelial Growth Factor C on Lymphangiogenesis and Angiogenesis of Pancreatic Cancer

Effects of Endostatin-Vascular Endothelial Growth Inhibitor Chimeric Recombinant Adenoviruses on Antiangiogenesis

Suppression of Lung Tumor Growth and Metastasis in Mice by Adeno-Associated Virus-Mediated Expression of Vasostatin

Effect of angiostatin gene on growth and metastasis of pancreatic carcinoma strain PC-3 orthotopic implantation model in mice

A Gene Therapy for Cancer Based on the Angiogenesis Inhibitor, Vasostatin.

Inhibitory Effect of Adeno-Associated Virus-Mediated Gene Transfer of Human Endostatin on Hepatocellular Carcinoma

Effect of VEGF-C Interfering on the Lymphangiogenesis of a Mouse Model Bearing Human Colon Cancer

[Inhibitive Effects of Recombinant Adenovirus-Mediated Human Endostatin on the Growth of Human Hepatocellular Carcinoma Xenograft in Nude Mice].

Suppressive Effect of Recombinant Adenovirus-mediated Endostatin Gene by Intraperitoneal Injection on Pancreatic Cancer in an Orthotropic Nude Mouse Model

Inhibition of Growth and Metastases of Inoculated Human Prostate Cancer in Nude Mice by Antisense Vascular Endothelial rowth Factor

[Inhibition of Alphastatin on Angiogenesis in Human Endothelial Cells and the Mechanism Thereof: an Experimental Study].

Therapeutic effect of endostatin-vascular endothelial growth inhibitor recombinant adenoviruses on gastric carcinoma in nude mice

Effect of recombinant adenovirus-mediated endostatin-soluble vascular endothelium growth inhibitor fusion gene on corneal neovascularization

The inhibitory effects of endostatin gene transfer on the growth of breast cancer cells in vivo and in vitro